The University of Chicago Header Logo

Connection

Gini Fleming to E-Selectin

Back to Details
This is a "connection" page, showing publications Gini Fleming has written about E-Selectin.
Gini Fleming
Connection Strength
0.020
E-Selectin
  1. Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008 Jan 01; 26(1):76-82.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.